Illumina Drives Cancer Breakthroughs Using Multiomics Tools
At AGBT, researchers reveal new findings from studies leveraging Illumina’s multiomics solutions Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina’s...